Immudyne Inc (IMMD) 0.2210 $IMMD
lmmuDyne Announces Q2 2016 Net Sales Up 343%, Adjusted Non-GAAP Net Income
GlobeNewswire - Mon Aug 15, 7:30AM CDT
lmmuDyne (OTCQB:IMMD) announced today its financial results for the quarter ended June 30, 2016 and provided an update on its interim results for the first six weeks of Q3 2016.
ImmuDyne Appoints Two Industry Leaders to Newly-Formed Business Development Advisory Board
GlobeNewswire - Wed Jun 01, 10:41AM CDT
ImmuDyne (OTCQB:IMMD) announced today the appointment of Messrs. Adam Lefton and Michael Levin to a newly-formed advisory board formed to explore further commercialization opportunities for the Company's proprietary oral beta-glucan products.
NHC.TO: 4.04 (+0.08), HLTH: 3.13 (+0.06)
ImmuDyne Increases its Ownership Interest In Innate Scientific to 78%; Expects Sales of $10M in 2016
GlobeNewswire - Fri Apr 08, 7:30AM CDT
ImmuDyne, Inc. (OTC:IMMD) today announced that the company increased its ownership interest in Innate Scientific to 78.16667% ("Innate"
, a joint venture focused on direct-to-consumer online marketing. Innate Scientific is the trade name for the joint venture and its legal name is Immudyne PR LLC under the laws of Puerto Rico.
ImmuDyne Engages One Equity Research to Reach New Investors With Company's Value Proposition
GlobeNewswire - Thu Dec 10, 7:30AM CST
ImmuDyne, Inc. (OTCQB:IMMD) today announced that it has engaged One Equity Research LLC ("One Equity" to provide advisory services and research covering milestone or inflection points in the Company's development.
ImmuDyne and Innate Scientific Announce Collaboration and Licensing Agreement to Launch National Skin Care Line Based on ImmuDyne's Yeast Beta Glucan Technology Portfolio
GlobeNewswire - Tue Oct 13, 7:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD), a health, wellness and skincare company commercializing a portfolio of proprietary topical and orally delivered products that rely on ImmuDyne's patented and pure Yeast Beta Glucan ingredients, has entered into a semi-exclusive marketing agreement with Innate Scientific, LLC to launch a complete skin care regime that will be based primarily on strategic ingredients provided by ImmuDyne. Innate Scientific's leadership team has deep experience in the direct marketing space and an impressive track record creating national brands expeditiously and profitably. Importantly, Innate Skincare's founders have agreed to provide up to $2,000,000 in non-dilutive capital to finance direct marketing initiatives.
ImmuDyne Sales Continue to Improve, Sees Earnings Ahead
GlobeNewswire - Thu Oct 01, 7:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) ImmuDyne today announced nine month revenues grew to $844,268 in 2015 from $554,509 in 2014. Revenues for the 3 quarter rose 40%, year over year, to approximately $279,000. As previously reported, ImmuDyne is capitalizing on its strong Intellectual Property and is pursuing additional sales and marketing opportunities, while continuing strong expense controls.
Sven Rohmann M.D., PhD, M.B.A. Joins the Board of Directors at Immudyne, as the Company Prepares to Announce a Lead Application for Its Proprietary Oral and Topical Delivery Technology
GlobeNewswire - Wed Sep 16, 8:34AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) - announced today that Sven Rohmann M.D., PhD, M.B.A. has joined its Board of Directors.
MRK: 63.32 (-0.26)
ImmuDyne Progress Report
GlobeNewswire - Thu Apr 02, 10:59AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announces 1 quarter revenues rose more than 50%, year over year, to approximately $288,000. Additionally, as reported in its recent 10K, ImmuDyne is hiring additional sales and marketing executives, each with performance based contracts, allowing ImmuDyne to continue to manage strong expense controls.
MRK: 63.32 (-0.26)
IPA Endorses ImmuDyne Line of Immune Support Supplements
GlobeNewswire - Thu Mar 26, 11:48AM CDT
Today, ImmuDyne (immd) announced that the Independent Pharmacy Alliance will endorse ImmuDyne's full line of Immune Support Products. IPA President John Giampolo stated, "I have been using INR Wellness for more than 10 years and my enhanced immune system has protected me beyond all my expectations. You may recall that about 10 years ago, IPA launched a complex vitamin program to complement your patients' particular disease states. During the educational process to over 600 IPA members provided by many PhD nutritional experts, I discovered ImmuDyne and how its preventative impact affected me. I can highly recommend this product for all members, their families and their patients. Because of my experience, IPA has contracted with ImmuDyne at very special and affordable pricing. Your patients will surely appreciate your care when their resistance to seasonal illness improves."
ImmuDyne Hires Todd Goldman as Senior Vice President of Marketing and Sales
GlobeNewswire - Tue Feb 10, 8:30AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today the hiring of Todd Goldman as Senior Vice President of Marketing and Sales.
ImmuDyne Teams Again With HellaWella
GlobeNewswire - Thu Feb 05, 10:01AM CST
ImmuDyne, Inc. (OTCQB:IMMD) and media partner HellaWella announced today the second published content ("An aging immune system puts you at higher risk for viral illnesses and cancer. Here's how to fight back" by Dr. Stephen Petteruti), which can be accessed here:
ImmuDyne Teams With HellaWella
GlobeNewswire - Mon Jan 26, 10:12AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today that It has chosen HellaWella as a media partner. The first published content can be accessed here:
lmmuDyne Announces Q2 2016 Net Sales Up 343%, Adjusted Non-GAAP Net Income
GlobeNewswire - Mon Aug 15, 7:30AM CDT
lmmuDyne (OTCQB:IMMD) announced today its financial results for the quarter ended June 30, 2016 and provided an update on its interim results for the first six weeks of Q3 2016.
ImmuDyne Appoints Two Industry Leaders to Newly-Formed Business Development Advisory Board
GlobeNewswire - Wed Jun 01, 10:41AM CDT
ImmuDyne (OTCQB:IMMD) announced today the appointment of Messrs. Adam Lefton and Michael Levin to a newly-formed advisory board formed to explore further commercialization opportunities for the Company's proprietary oral beta-glucan products.
NHC.TO: 4.04 (+0.08), HLTH: 3.13 (+0.06)
ImmuDyne Increases its Ownership Interest In Innate Scientific to 78%; Expects Sales of $10M in 2016
GlobeNewswire - Fri Apr 08, 7:30AM CDT
ImmuDyne, Inc. (OTC:IMMD) today announced that the company increased its ownership interest in Innate Scientific to 78.16667% ("Innate"
, a joint venture focused on direct-to-consumer online marketing. Innate Scientific is the trade name for the joint venture and its legal name is Immudyne PR LLC under the laws of Puerto Rico. ImmuDyne Engages One Equity Research to Reach New Investors With Company's Value Proposition
GlobeNewswire - Thu Dec 10, 7:30AM CST
ImmuDyne, Inc. (OTCQB:IMMD) today announced that it has engaged One Equity Research LLC ("One Equity"
to provide advisory services and research covering milestone or inflection points in the Company's development. ImmuDyne and Innate Scientific Announce Collaboration and Licensing Agreement to Launch National Skin Care Line Based on ImmuDyne's Yeast Beta Glucan Technology Portfolio
GlobeNewswire - Tue Oct 13, 7:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD), a health, wellness and skincare company commercializing a portfolio of proprietary topical and orally delivered products that rely on ImmuDyne's patented and pure Yeast Beta Glucan ingredients, has entered into a semi-exclusive marketing agreement with Innate Scientific, LLC to launch a complete skin care regime that will be based primarily on strategic ingredients provided by ImmuDyne. Innate Scientific's leadership team has deep experience in the direct marketing space and an impressive track record creating national brands expeditiously and profitably. Importantly, Innate Skincare's founders have agreed to provide up to $2,000,000 in non-dilutive capital to finance direct marketing initiatives.
ImmuDyne Sales Continue to Improve, Sees Earnings Ahead
GlobeNewswire - Thu Oct 01, 7:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) ImmuDyne today announced nine month revenues grew to $844,268 in 2015 from $554,509 in 2014. Revenues for the 3 quarter rose 40%, year over year, to approximately $279,000. As previously reported, ImmuDyne is capitalizing on its strong Intellectual Property and is pursuing additional sales and marketing opportunities, while continuing strong expense controls.
Sven Rohmann M.D., PhD, M.B.A. Joins the Board of Directors at Immudyne, as the Company Prepares to Announce a Lead Application for Its Proprietary Oral and Topical Delivery Technology
GlobeNewswire - Wed Sep 16, 8:34AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) - announced today that Sven Rohmann M.D., PhD, M.B.A. has joined its Board of Directors.
MRK: 63.32 (-0.26)
ImmuDyne Progress Report
GlobeNewswire - Thu Apr 02, 10:59AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announces 1 quarter revenues rose more than 50%, year over year, to approximately $288,000. Additionally, as reported in its recent 10K, ImmuDyne is hiring additional sales and marketing executives, each with performance based contracts, allowing ImmuDyne to continue to manage strong expense controls.
MRK: 63.32 (-0.26)
IPA Endorses ImmuDyne Line of Immune Support Supplements
GlobeNewswire - Thu Mar 26, 11:48AM CDT
Today, ImmuDyne (immd) announced that the Independent Pharmacy Alliance will endorse ImmuDyne's full line of Immune Support Products. IPA President John Giampolo stated, "I have been using INR Wellness for more than 10 years and my enhanced immune system has protected me beyond all my expectations. You may recall that about 10 years ago, IPA launched a complex vitamin program to complement your patients' particular disease states. During the educational process to over 600 IPA members provided by many PhD nutritional experts, I discovered ImmuDyne and how its preventative impact affected me. I can highly recommend this product for all members, their families and their patients. Because of my experience, IPA has contracted with ImmuDyne at very special and affordable pricing. Your patients will surely appreciate your care when their resistance to seasonal illness improves."
ImmuDyne Hires Todd Goldman as Senior Vice President of Marketing and Sales
GlobeNewswire - Tue Feb 10, 8:30AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today the hiring of Todd Goldman as Senior Vice President of Marketing and Sales.
ImmuDyne Teams Again With HellaWella
GlobeNewswire - Thu Feb 05, 10:01AM CST
ImmuDyne, Inc. (OTCQB:IMMD) and media partner HellaWella announced today the second published content ("An aging immune system puts you at higher risk for viral illnesses and cancer. Here's how to fight back" by Dr. Stephen Petteruti), which can be accessed here:
ImmuDyne Teams With HellaWella
GlobeNewswire - Mon Jan 26, 10:12AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today that It has chosen HellaWella as a media partner. The first published content can be accessed here:
